Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Sy Mukherjee
Sy Mukherjee is a former health care reporter for
Fortune.
Page 11 of 100
Health
The CDC’s Thanksgiving warning isn’t really about travel
By
Sy Mukherjee
Newsletters
The sad science of pandemic grief
By
Sy Mukherjee
Health
Why it’s hard to process 250,000 COVID deaths
By
Sy Mukherjee
Newsletters
The scientific link between Pfizer’s and Moderna’s COVID vaccines
By
Sy Mukherjee
Health
Creating a COVID vaccine is only half the battle
By
Sy Mukherjee
Newsletters
The election might be top of mind but 234,000 people are dead, with many in swing states
By
Sy Mukherjee
Health
The science behind the leading COVID vaccine candidates
By
Sy Mukherjee
Newsletters
Two tales of innovation from CVS and Pfizer
By
Sy Mukherjee
Health
We don’t know enough about COVID antibodies to count on them
By
Sy Mukherjee
Health
The COVID vaccine timeline: Where the candidates are now—and what’s still to come
By
Sy Mukherjee
Conferences
Pfizer’s high-tech plan to track every dose of its experimental COVID vaccine
By
Sy Mukherjee
Conferences
The moment CVS transformed into a different kind of health care company
By
Sy Mukherjee
Health
Despite Trump’s claims, the Dept. of Defense doesn’t plan to lead vaccine distribution
By
Sy Mukherjee
Newsletters
Gilead just got the first FDA coronavirus treatment approval, but there are still problems
By
Sy Mukherjee
Health
Can COVID-19 cause diabetes? Here’s what we know
By
Sy Mukherjee